{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:17:33Z","timestamp":1790363853308,"version":"4.1.0"},"reference-count":47,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>In France, the risk of HIV transmission by transfusion was reduced by implementing pooled nucleic acid testing (NAT) in 2001 and individual NAT in 2010. We report here the first case in France of transfusion of human immunodeficiency virus (HIV)\u2010infected blood donated during HIV pre\u2013ramp\u2010up phase that tested individual NAT negative.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Blood donations are screened for HIV antibodies and HIV RNA (ProcleixUltrio, Grifols; limit of detection at 95%, 23 copies\/mL). When a repeat donor tests positive for HIV, a repository sample from the previous donation is tested with the Cobas Taqman HIV\u20101 test (CTM, Roche; limit of detection at 95%, 17 copies\/mL).<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>In August 2017, a 57\u2010year\u2010old male repeat donor was screened positive for HIV antibodies and RNA (plasma viral load, 11,599 copies\/mL). The previous donation had tested negative with Ultrio in March 2017 but was positive with an unquantifiable plasma viral load when tested with CTM. Sequencing showed no mismatch between Ultrio primers\/probes and the target sequence. HIV transmission was excluded by lookback studies in the recipient of platelets, which had been pathogen reduced, but not in the recipient of RBCs due to premature death.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p>This case demonstrates that the risk of contaminated donations due to the early HIV infection phase going undetected by highly sensitive NAT is real but exceptional. The absence of transmission to the platelets recipient could be due to the very low viral inoculum and\/or to the efficacy of the viral inactivation. This case also highlights the additional value of a systematic donation archiving and the importance of donor education and predonation selection.<\/jats:p><\/jats:sec>","DOI":"10.1111\/trf.15203","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T07:49:40Z","timestamp":1550648980000},"page":"2046-2053","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Transfusion of HIV\u2010infected blood products despite highly sensitive nucleic acid testing"],"prefix":"10.1111","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8540-2196","authenticated-orcid":false,"given":"Pierre","family":"Cappy","sequence":"first","affiliation":[{"name":"D\u00e9partement des Agents Transmissibles par le Sang, Centre National de R\u00e9f\u00e9rence Risques Infectieux Transfusionnels Institut National de la Transfusion Sanguine (INTS)  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Barlet","sequence":"additional","affiliation":[{"name":"ETS Auvergne Rh\u00f4ne Alpes, Laboratoire de qualification biologique des dons Est Etablissement Fran\u00e7ais du Sang  Metz\u2010Tessy France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Lucas","sequence":"additional","affiliation":[{"name":"D\u00e9partement des Agents Transmissibles par le Sang, Centre National de R\u00e9f\u00e9rence Risques Infectieux Transfusionnels Institut National de la Transfusion Sanguine (INTS)  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Tinard","sequence":"additional","affiliation":[{"name":"ETS grand est, P\u00f4le des vigilances Etablissement Fran\u00e7ais du Sang  Nancy France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Pillonel","sequence":"additional","affiliation":[{"name":"D\u00e9partement des maladies infectieuses Sant\u00e9 publique France  Saint\u2010Maurice France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Gross","sequence":"additional","affiliation":[{"name":"Etablissement Fran\u00e7ais du Sang  Saint Denis France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Tiberghien","sequence":"additional","affiliation":[{"name":"Etablissement Fran\u00e7ais du Sang  Saint Denis France"},{"name":"Unit\u00e9 mixte de recherche 1098 INSERM Universit\u00e9 de Franche\u2010Comt\u00e9, Etablissement Fran\u00e7ais du Sang  Besan\u00e7on France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syria","family":"Laperche","sequence":"additional","affiliation":[{"name":"D\u00e9partement des Agents Transmissibles par le Sang, Centre National de R\u00e9f\u00e9rence Risques Infectieux Transfusionnels Institut National de la Transfusion Sanguine (INTS)  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"e_1_2_7_2_1","volume-title":"Blood safety in the new millennium","author":"Busch MP","year":"2001"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2011.01506.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01966.x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2005.00926.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2011.07.007"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2011.07.001"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12204"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02203.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02942.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03281.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12298"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1246"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.69.8.5087-5094.1995"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2004.20.958"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00012-13"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.3.1234-1240.2000"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.22.11273-11282.2002"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2011.12.001"},{"key":"e_1_2_7_20_1","unstructured":"LANL HIV sequence databases [Internet]. [accessed 2018 Dec 20] Available from:https:\/\/www.hiv.lanl.gov\/."},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02217-07"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00602-09"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2017.05.014"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyl037"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyl156"},{"key":"e_1_2_7_26_1","first-page":"1","volume-title":"Clinical Microbiology","author":"Truant AL","year":"2016"},{"key":"e_1_2_7_27_1","first-page":"40A","article-title":"Third reported US case of breakthrough HIV transmission from NAT screened blood","volume":"43","author":"Stramer SL","year":"2003","journal-title":"Transfusion"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0042-9007.2004.00416.x"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20097"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03364.x"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01847.x"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.02012.x"},{"key":"e_1_2_7_33_1","unstructured":"LaffoonB LeviM BowerWA KuehnertM BrooksJT SelikRM et al.HIV transmission through transfusion. MMWR Morb Mortal Wkly Rep2010;1\u20134."},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12316"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12769"},{"issue":"1","key":"e_1_2_7_36_1","first-page":"1","article-title":"First report of Human Immunodeficiency Virus breakthrough transmission in Thailand after mandatory 6\u2010minipool nucleic acid testing","volume":"109","author":"Rujirojindakul P","year":"2015","journal-title":"Vox Sang"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13409"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2017.06.020"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01965.x"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.9.4441-4447.2005"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-016-0324-3"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msw054"},{"issue":"1","key":"e_1_2_7_43_1","first-page":"854","article-title":"Assessment of HIV transfusion transmission risk in South Africa: a 10\u2010year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes","volume":"17","author":"Vermeulen M","year":"2018","journal-title":"Transfusion"},{"issue":"1","key":"e_1_2_7_44_1","first-page":"1","article-title":"Minipool NAT HIV\u20101 breakthrough transmission cases and probability of interdiction by current small pool or individual\u2010dination NAT screening systems","volume":"96","author":"Kleinman S","year":"2018","journal-title":"Vox Sang"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70167-5"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02423-08"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02322.x"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw365"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.15203","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.15203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T19:00:00Z","timestamp":1694372400000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.15203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,19]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1111\/trf.15203"],"URL":"https:\/\/doi.org\/10.1111\/trf.15203","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,19]]},"assertion":[{"value":"2018-10-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}